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Abstract
Microcystin-LR (MCLR)-induced hepatotoxicity was assessed in vivo in male Sprague^Dawley rats (150^350 g) using
magnetic resonance imaging (MRI). Following the intraperitoneal administration of MCLR (LD50), a region of damage,
characterised by increased signal intensity on T2-weighted images, was seen proximal to the hepatic portal vein in the liver.
Similarly, increased signal intensity was seen in the chemical-shift selective images (CSSI) of water frequency, proximal to the
hepatic portal vein in the liver. This indicates that the increased signal intensity observed in the T2-weighted images was due
to an increased amount of magnetic resonance (MR) visible protons in the tissue which represents an oedematous response.
Image analysis of regions of apparent damage around the hepatic portal vein indicated a statistically significant increase in
signal intensity in this region. Mitochondrial swelling and lipid inclusions were observed by transmission electron microscopy
(TEM) in samples obtained from the oedematous regions of the liver using spatial coordinates from the magnetic resonance
(MR) images. Massive haemorrhagic necrosis and nuclear swelling were observed by light microscopy in the centrilobular
regions of the lobules. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Many strains of cyanobacteria (or blue-green al-
gae) are universally known for their production of
potentially lethal toxins. Toxic water blooms have
been attributed to livestock and wildlife deaths,
and have caused severe hepatic and gastrointestinal
illness in humans world-wide. Microcystis aeruginosa
is one of the most commonly found strains of
cyanobacteria in large algal blooms [1]. M. aerugi-
nosa is a single-celled, colonial cyanobacterium,
common in both eutrophic fresh- and brackish
waters [1,2]. The primary group of toxins produced
by M. aeruginosa are the microcystins which are
liver-speci¢c cyclic heptapeptide toxins. Microcys-
tin-LR (MCLR), or cyclo-D-Ala-L-Leu-erythro-L-
methyl-D-isoAsp-L-Arg-ADDA-D-isoGlu-N-methyl-
dehydroAla, where ADDA is 3-amino-9-methoxy-
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2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid, is the
most potent cyanobacterial hepatotoxin known
[3].
Microcystins utilise the bile acid transport system
to enter the hepatocytes where they bind and inhibit
the liver protein phosphatases 1 (PP1) and 2A
(PP2A) [4,5]. These protein phosphatases are respon-
sible for the dephosphorylation of serine and threo-
nine residues on a variety of regulatory and structur-
al proteins in cells and as such, play a major role in
the maintenance of cytoskeletal networks [4]. Recent
research by numerous investigators suggests that the
mechanism of action of MCLR-induced hepatocellu-
lar damage involves a PP2A inhibition-induced in-
crease in the phosphorylation of intermediate ¢la-
ments [6]. MCLR-induced morphological changes
in hepatocytes seen with histology and electron mi-
croscopy are consistent with the hypothesis that
MCLR induces alterations in the hepatocyte cyto-
skeleton. Initial changes are con¢ned to shape
changes in the hepatocyte plasma membrane includ-
ing plasma membrane blebbing and invagination,
and rounding of hepatocytes [7]. Later changes in-
clude extensive hepatic haemorrhage, and general ne-
crosis in the liver including hepatocyte-to-hepatocyte
dissociation and disruption of the sinusoidal endo-
thelium. Laboratory animals administered a lethal
dose of MCLR intraperitoneally (i.p.) die within
1^3 h post-injection and reveal, upon necroscopy,
enlarged livers engorged with blood [8,9]. Death is
attributed to haemorrhagic shock resulting from
massive hepatocellular necrosis and collapse of the
hepatic parenchyma [8,10].
To date, in vivo information available on the hep-
atotoxicity of MCLR has been limited to the deter-
mination of LD50 values in rodents. A non-invasive
in vivo technique such as magnetic resonance imag-
ing (MRI) o¡ers the advantage of providing infor-
mation whilst maintaining the integrity of the liver
and its natural physiological and biochemical envi-
ronment. The objective of this study is to localise and
characterise the in vivo cytotoxic events that arise
from MCLR-induced hepatotoxicity in a living rat
model using MRI with the hope of establishing
MRI as a valid in vivo diagnostic tool for the assess-
ment of microorganism toxin-induced tissue damage
in mammalian species.
2. Materials and methods
2.1. Animals
Male, 150^350 g, Sprague^Dawley rats were ob-
tained from Animal Services Centre (Canningvale,
WA, Australia), and housed in the James Cook Uni-
versity animal facility (n = 10). Rats were fed with
commercial rat chow and water ad libitum, and
kept on a 12:12-h light/dark cycle. Animals were
fasted 18^24 h prior to all experiments which is com-
mon practice when administering inhalation anaes-
thetics. Ethics approval was obtained from the Ex-
perimentation Ethics Review Committee of James
Cook University (ethics approval no. A404).
2.2. Toxin and induction of hepatotoxicity
Microcystin-LR (MCLR) (0.5 mg) was obtained
from Bio Scienti¢c (Gymea, NSW, Australia) and
stored at 0‡C. Rats were anaesthetised with 2% iso-
£urane via inhalation at a rate of 1.0 litre O2/min. A
Te£on tubing (0.44 mm diameter) was placed within
the peritoneal cavity. The toxin was dissolved in sal-
ine prior to use to produce a stock solution with a
concentration of 1 mg/ml in saline. Hepatotoxicity
was induced in anaesthetised animals via a single
intraperitoneal (i.p.) injection of LD50 (50 Wg/kg
rat) of MCLR stock solution (made up to 200-Wl
aliquots with saline) in all studies, after control
data was obtained.
2.3. Magnetic resonance imaging (MRI)
MRI measurements were made using a Varian IN-
OVA UNITY 7.0 Tesla/18 cm horizontal bore small
animal imaging spectrometer. Rats were placed in a
1H-NMR birdcage probe (n = 6). Respiratory gating
was used to trigger acquisitions of the phase-encod-
ing steps in the imaging sequences to minimise mo-
tion artefacts from respiratory breathing [11]. T1-
weighted images (TR = 800 ms, TE = 30 ms) and
T2-weighted images (TR = 2000 ms, TE = 60 ms)
were obtained in the transverse (axial) plane using
a gated multislice spin echo sequence. Chemical-shift
selective images (CSSI) (TR = 800 ms, TE = 30 ms)
were obtained on the water and lipid methylene
peak frequencies. Images were acquired using 128
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phase-encoding steps, 4 acquisitions per step, with
¢eld of view of 6U8 cm2 and a slice thickness of
2 mm. Images were obtained prior to treatment
with MCLR, each rat thus serving as its own control,
and over a period of 3 h following administration of
the toxin. Image analysis was performed on proton
water signal intensities in selected 6-mm2 regions
from magnetic resonance (MR) images of control
and MCLR-treated rat livers using the software Im-
agePro Plus.
Following MRI experiments, the anaesthetised rats
were euthanised via cervical dislocation and their liv-
ers excised for microscopic assessment. Non-treated
anaesthetised rats were also euthanised via cervical
dislocation and their livers excised to serve as con-
trols for microscopic assessment (n = 4).
2.4. Transmission electron microscopy (TEM)
Small sections of liver approximately 1 mm3 were
removed from regions of apparent damage using
magnetic resonance imaging spatial coordinates,
and immersed in a standard TEM ¢xative solution
consisting of 10% glutaraldehyde in Sorenson’s phos-
phate bu¡er (200 ml distilled water, 1.57 g sodium
phosphate dibasic and 0.33 g potassium phosphate
monobasic; pH 7.4) for 1 h, after which they were
washed and stored in Sorenson’s phosphate bu¡er.
The TEM specimens were subsequently post-¢xed
with 1% osmium tetroxide (OsO4) in phosphate bu¡-
er for 1 h after which they were washed in phosphate
bu¡er. The specimens were then dehydrated in a
graded ethanol series of 70^100%, in¢ltrated with
Spurr’s resin, and then embedded in Spurr’s resin.
Thin sections (1 Wm) of the specimens were cut using
a LKB ultramicrotome, mounted on copper grids,
stained with uranyl acetate and lead citrate, and
viewed with a JEOL transmission electron micro-
scope (model 2000 FX).
2.5. Histology
After the TEM sections were removed, the remain-
der of the liver was immersed in 10% formalin (10%
formaldehyde in water). The tissues were subse-
quently dehydrated in ethanol, cleared in xylene
and embedded in para⁄n wax. Sections (5 Wm)
were cut using a Spencer microtome (model 280),
stained with haematoxylin and eosin and mounted
on slides in DePex. Photomicrographs were obtained
using a Leitz Vario-orthomat photomicroscope.
2.6. Statistics
The image analysis results were analysed using the
software Statistica (Statsoft, Tulsa, OK, USA). A
two-tailed dependent t-test was used to analyse
data from 6-mm2 regions of apparent damage
around the hepatic portal vein, and non-apparent
damage from a non-hepatic portal vein region of
the liver, both before (control) and after MCLR
treatment.
Fig. 1. (A) Transverse T2-weighted 1H-NMR image of a control rat obtained from the abdominal region with the use of respiratory
gating. Assignments: (1) spinal cord, (2) aorta, (3) hepatic portal vein, (4) muscle, (5) liver and (6) stomach. (B) Transverse T2-
weighted 1H-NMR image slice through the liver 2 h 30 min after i.p. administration of a LD50 of MCLR. Note the localised area of
high signal intensity around the hepatic portal vein (n = 6).
BBADIS 61845 29-7-99
S.A. Sturgeon, R.A. Towner / Biochimica et Biophysica Acta 1454 (1999) 227^235 229
3. Results
3.1. MRI
Both T1- and T2-weighted images of MCLR-
treated rats in the liver region indicated an increase
in signal intensity proximal to the hepatic portal vein
in comparison to the control images (Fig. 1A,B). In
order to determine if the signal intensity was propor-
tional to the amount of MR-visible water protons in
the tissue chemical-shift selective imaging (CSSI) was
used. Chemical-shift selective images of the water
and methylene lipid hydrogen frequencies are shown
in Figs. 2 and 3. An increase in signal intensity prox-
imal to the hepatic portal vein is observed in the
water chemical-shift selective images of treated rats
(Fig. 2B) in comparison to control images (Fig. 2A).
No changes were detected in the fat chemical-shift
selective images of the MCLR-treated rats (Fig. 3B)
when compared to control images (Fig. 3A).
Image analysis of 6-mm2 regions of apparent and
non-apparent tissue damage from MR images indi-
cated a signi¢cant increase in signal intensity in the
region surrounding the hepatic portal vein, but not
in the non-hepatic portal vein region of the liver
(Fig. 4A,B). Previous studies in our research group
have shown that over a period of 3^4 h, saline-
treated rat liver images show no change in signal
intensity in any region of the liver [12].
3.2. TEM
Transmission electron microscopy of liver sections
obtained from regions of apparent damage detected
in the MRI studies of MCLR-treated rats revealed
subcellular changes. Mitochondrial swelling and lipid
Fig. 2. (A) Transverse chemical-shift selective (water) 1H-NMR image slice through the liver (control). (B) Transverse chemical-shift
selective (water) 1H-NMR image slice through the liver obtained 3 h 15 min after i.p. administration of a LD50 of MCLR. Note the
localised area of high water proton signal intensity around the hepatic portal vein (n = 6).
Fig. 3. (A) Transverse chemical-shift selective (fat) 1H-NMR image slice through the liver (control). (B) Transverse chemical-shift se-
lective (fat) 1H-NMR image slice through the liver obtained 3 h 15 min after i.p. administration of a LD50 of MCLR. Note no
change in lipid proton signal intensity around the hepatic portal vein (n = 6).
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inclusions were found (Fig. 5B). These changes were
absent in the liver sections obtained from the control
rats (Fig. 5A).
3.3. Histology
Light microscopy of liver sections obtained from
the right- and right medial liver lobes of rats exposed
to a LD50 of MCLR revealed cellular changes in the
centrilobular regions of the liver lobules. Severe in-
trahepatic haemorrhage (Fig. 7A), hepatocellular ne-
crosis (Fig. 7B) and nuclear swelling (Fig. 8B) were
found. These changes were absent in the liver sec-
tions obtained from the control rats (Fig. 6A and
8A), and in non-centrilobular regions of treated liver
(Fig. 6B).
Fig. 4. (A) Transverse T2-weighted 1H-NMR image of a control rat obtained from the abdominal region with the use of respiratory
gating. See Fig. 1A for anatomical assignments. The highlighted 6-mm2 regions indicate areas assessed for NMR image intensity. (B)
Histogram depicting liver regions assessed for NMR image intensity as shown in A. Image water proton intensities were assessed in
control and MCLR-treated rat livers in a region surrounding the hepatic portal vein (HPV) and a non-hepatic portal vein (non-HPV)
region. Statistical signi¢cance (*P6 0.01) between the HPV control group and the HPV MCLR-treated group (n = 6).
Fig. 5. Electron micrographs from control rat liver (A) and liver of a MCLR-treated (LD50 = 50 Wg/kg) rat (B). Mitochondrial swelling
(*) and lipid inclusions (arrow) can be seen in the MCLR-treated rat but not in the control. Bar = 2 Wm.
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4. Discussion
Since its introduction in the early 1980s, MRI has
proven to be a useful tool in the detection of chronic
disease states and tissue damage in clinical and bio-
medical research. To date, MRI has been predomi-
nantly used for diagnostic purposes, rather than for
toxicological studies [11]. This technique was initially
applied to diagnose cancer and has proven to be
invaluable in the di¡erentiation between normal
and neoplastic tissue in a range of soft tissues in
the body. In recent years, the use of MRI to assess
Fig. 6. Photomicrographs from control rat liver (A) and from a non-centrilobular region of MCLR-treated (LD50 = 50 Wg/kg) rat liver
(B). Note that there is no apparent damage in the non-centrilobular region of the MCLR-treated rat liver. HpE, U80.
Fig. 7. Photomicrographs from centrilobular regions of MCLR-treated (LD50 = 50 Wg/kg) rat liver depicting severe intrahepatic
haemorrhage (A) and hepatocellular necrosis (B). Note the in¢ltration of in£ammatory cells (arrow) in necrotic tissue. HpE, U80.
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in vivo toxicity of various hepatotoxins, namely CCl4
[11^17], and other halocarbons [11], has been dem-
onstrated. The advantage of MRI is that it is a non-
invasive, in vivo technique which can obtain in situ
information serially, or repeatedly, as well as reduc-
ing the number of experimental animals used.
MCLR-induced pathological changes in the liver
were monitored in vivo using 1H-NMR T2-weighted
imaging and CSSI (water and fat). The MR images
exhibited remarkable soft tissue di¡erentiation. Res-
piratory gating was used in this study to minimise
respiratory artefacts normally seen in abdominal im-
ages. Few experimental MRI studies have ever been
conducted on the liver due to respiratory motion
which can degrade image quality.
An increase in signal intensity was observed prox-
imal to the hepatic portal vein of the liver in the T2-
weighted images of the microcystin-treated rats (Figs.
1 and 4). T1 (spin lattice or longitudinal relaxation
time) and T2 (spin^spin or transverse relaxation
time) values are the properties that modulate signal
intensity from tissues and are dependent upon the
composition of that tissue [18]. Free, or ‘unbound’,
water has a long T1, whereas fat has a short T1.
Since water has a long T1, it follows that tissues
with a high water content will also have a long T1.
Pathological/diseased tissues often have increased in-
tracellular water, and as such, demonstrate a prolon-
gation of T1 and T2 [19]. The prolonged T1 and T2
of pathological/diseased tissue, set against the in-
trinsically short T1 and T2 of the surrounding ‘nor-
mal’ tissue creates a detectable tissue contrast [19]. In
the MR images this is usually represented by an in-
crease in signal intensity.
Whilst standard spin echo imaging techniques
might provide an excellent means of distinguishing
between tissues and visualising pathologies, determi-
nation of the type of damage seen is di⁄cult using
MRI [20]. For example, tumour and surrounding
oedema both show an increased signal intensity in
T2-weighted spin echo images, but discrimination be-
tween the two is often impossible [20]. CSSI can
speci¢cally di¡erentiate between fat and water accu-
mulation associated with lesions [21]. This is due to
the distinct di¡erence between the resonant fre-
quency of fat protons and water protons [21]. The
increase in signal intensity proximal to the hepatic
portal vein in the T2-weighted images of MCLR-
treated rat liver corresponds to that seen in the water
chemical-shift selective images (Fig. 2). This indicates
that the damage observed is due to a hydropic or
oedematous response. These results were con¢rmed
by histological and electron microscopic examina-
tions of MCLR-treated rat liver. Fat chemical-shift
Fig. 8. Photomicrographs from centrilobular regions of control rat liver (A) and MCLR-treated (LD50 = 50 Wg/kg) rat liver (B). Nu-
clear swelling (swelling) can be seen in the MCLR-treated rat but not in the control. HpE, U200.
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selective imaging was not able to detect substantial
changes in lipid metabolism (Fig. 3). Preliminary
on-going investigations using in vivo localised
NMR spectroscopy to assess changes in lipid metab-
olism in the livers of MCLR-treated rats are cur-
rently in progress in our research group (unpublished
data).
Whilst MRI is able to localise tissue damage with-
in the liver, it only has a resolution of 1mm and thus,
is not able to provide information on which region/s
within the liver lobules the damage has occurred.
Histological examination of MCLR-treated rat liver
revealed damage in the centrilobular regions of the
lobules. Other regions within the lobules appeared to
be histologically ‘normal’. The apparent tissue injury
observed in the MR images is due to the distribution
of the toxin via the hepatic portal vein to hepatocytes
within the peripheral region of the hepatic portal
vein.
The principal pathological e¡ects of MCLR on rat
liver observed in this study was severe intrahepatic
haemorrhage (Fig. 7A) and hepatocellular necrosis
(Fig. 7B). Cell death, or necrosis, ensues when ‘irre-
versible’ damage occurs. The processes leading to cell
necrosis are a complex sequence of events which are
not clearly understood [22]. It has, however, long
been attributed to changes in intracellular distribu-
tion of calcium (Ca2) [22]. It is now generally ac-
cepted that changes in the intracellular distribution
of Ca2 is involved in the underlying toxicity of
many di¡erent, if not all, toxic compounds in di¡er-
ent tissues [22]. Intracellular Ca2 concentrations are
maintained by the action of transport systems which
transport Ca2 out of the cytosol and sequester it in
the mitochondria and endoplasmic reticulum [22].
Interference with these organelles, for example, mi-
tochondria swelling, can alter Ca2 homeostasis lead-
ing to cell necrosis [22]. In addition to hepatocyte
necrosis, necrosis of sinusoidal endothelial cells was
also evident. It is the disruption of the sinusoidal
endothelium that results in severe intrahepatic haem-
orrhage.
Nuclear swelling (Fig. 8) and mitochondrial swell-
ing (Fig. 5) are the result of hydropic change, which
is due to an in£ux of water into the hepatocyte [23].
It is common in acute hepatic injury produced by
toxic compounds and is often seen prior to cell ne-
crosis [23]. An increase in ion concentration in the
hepatocyte, usually due to membrane damage, leads
to an increase in osmotic pressure which causes water
to enter the cell [22]. If the swelling is excessive,
damage to the organelles will result.
Cytoplasmic lipid inclusions (Fig. 5) as observed in
TEM is usually evidence of fatty change and may
indicate an interference in lipid metabolism [23]. Tri-
glyceride synthesis occurs predominantly in the cen-
trilobular region of the lobule, thus fatty liver is a
common response to toxicity and is often the result
of interference with protein synthesis [22].
In addition to microscopic techniques, serum liver
enzyme analysis is also a useful measure of general
hepatocellular function. Hooser and colleagues [24]
observed signi¢cant elevations in the serum levels of
the liver enzymes alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) in fed rats
treated with 160 mg MCLR/kg i.p. [24]. Serum
ALT and AST levels started to increase 40 min and
6 h post-dosing, respectively [24]. A good correlation
was found between the initial hepatocyte lesions
(mild centrilobular dissociation of hepatocytes) seen
at 30 min and the initial increase in ALT at 40 min
[24]. These results are comparable to those obtained
by Nakano and colleagues [25], who also observed
signi¢cant elevations in serum ALT and AST levels
in mice treated with microcystin. Although serum
liver enzyme levels were not measured in this study,
the early elevated levels of ALT and AST observed
by other investigators correlate well with the time
scale of MRI detectable changes.
Finally, it should be noted that fasting appears to
enhance the toxicity of MCLR in rats[26,27]. Studies
by Miura and colleagues [26] on the hepatotoxicity
of MCLR in fed and fasted rats demonstrated that
the toxicity of MCLR was potentiated by overnight
fasting of rats. They observed that the necessary le-
thal dose (LD50) of MCLR was 122 mg/ kg and 72
mg/kg for fed [7,24,26,29] and fasted [9,20,26] rats,
respectively. Furthermore, they determined that the
median times to death of animals exposed to 100,
150 and 200 mg MCLR/kg were 31.9, 18.2 and
11.2 h for fed rats, and 1.8, 1.7 and 1.5 h for fasted
rats, respectively [26]. It has been suggested that
these di¡erences may be due to depletion of glycogen
stores and a decreased respiratory capacity in the
livers of fasted rats [6,26]. Although fasted rats
were used in our study, the dose of MCLR admin-
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istered to the rats complied with doses for fasted rats
used by other investigators [2,26,28].
In summary, this study has shown that MRI can
be used as a method for the in vivo assessment of
MCLR-induced liver damage in mammals. In partic-
ular, CSSI is very useful in determining the role of
oedema in the damage processes. The main advant-
age of MRI is that it provides non-invasive, non-
destructive in situ information that can be obtained
serially, or repeatedly. The results presented here are
from an LD50 study, which is substantially less toxic
than previously reported histological studies con-
ducted by other investigators using a LD100 [9,30].
In future studies it would be bene¢cial to investigate
whether a sub-lethal dose (LD25 or lower) of the
toxin would also produce MRI detectable tissue
damage in rat liver. These studies are currently in
progress in our laboratory.
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